• Site map
  • Contacts
  • Links
  • Home Page
  • EMVDA
  • EURHAVAC
  • Malaria - The Disease
  • Press Releases
  • EMVI Statutes
  • Board Members and Scientific Advisory Committee Members
  • Memoranda of Understanding and Intent
  • EMVI Strategy
  • Project Portfolio
    • Polyprotein FP9 PP and MVA PP Phase Ia Oxford
    • PfAMA1 Phase Ia Nijmegen
    • PfAMA1 - DDB-TDA
    • PfAMA1 - Second Generation
    • PfAMA1 - Phase Ib Mali
    • GMZ1 (PfGLURP) in the L lactis system
    • GMZ2 Phase Ia Tübingen
    • GMZ2 - DDA-TDB
    • GMZ2 Phase Ib in adults Gabon (AMANET)
    • GMZ2 Phase Ib in African children Gabon (AMANET)
    • JAIVAC-1 Phase I in adults
    • Var2-CSA DBL3-X and Var2CSA
    • TBV - Pf48-45
    • Completed Trials
  • Annual Reports
  • The Donors
  • Mid-Term Review 2005
  • Directives - Guidelines - Regulations
  • Meeting Reports
  • Procedures
  • Calls
  • Vacancies

Print page

PfAMA1 - DDA/TDB

Pending final toxicity evaluation, the project has been delayed.